U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C49H55NO14S
Molecular Weight 914.024
Optical Activity UNSPECIFIED
Defined Stereocenters 11 / 11
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMS-184476

SMILES

[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]4(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C5=CC=CC=C5)C6=CC=CC=C6)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@H](C[C@H]7OC[C@@]27OC(C)=O)OCSC)C4(C)C

InChI

InChIKey=UBJAHGAUPNGZFF-XOVTVWCYSA-N
InChI=1S/C49H55NO14S/c1-27-33(62-45(57)38(53)37(30-17-11-8-12-18-30)50-43(55)31-19-13-9-14-20-31)24-49(58)42(63-44(56)32-21-15-10-16-22-32)40-47(6,41(54)39(61-28(2)51)36(27)46(49,4)5)34(60-26-65-7)23-35-48(40,25-59-35)64-29(3)52/h8-22,33-35,37-40,42,53,58H,23-26H2,1-7H3,(H,50,55)/t33-,34-,35+,37-,38+,39+,40-,42-,47+,48-,49+/m0/s1

HIDE SMILES / InChI

Molecular Formula C49H55NO14S
Molecular Weight 914.024
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 11
E/Z Centers 0
Optical Activity UNSPECIFIED

Bristol-Myers Squibb developed BMS-184476 for the potential treatment of solid tumors. BMS-184476 participated in phase II clinical trials for patients with non-small-cell lung cancer, breast, and ovarian cancers. However, that development has been discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Preclinical antitumor activity of two novel taxanes.
2001
BMS-184476 Bristol-Myers Squibb.
2003 Jun
Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.
2005 Apr

Sample Use Guides

Fifty-six previously treated advanced NSCLC patients received BMS-184476 at a dose of 60 mg/m(2) administered intravenously over 1 h every 21 days.
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:55:34 GMT 2023
Edited
by admin
on Fri Dec 15 15:55:34 GMT 2023
Record UNII
3811W2NBZ8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BMS-184476
Common Name English
PACLITAXEL-7-METHYLTHIOMETHYL ETHER
Common Name English
7-O-((METHYLTHIO)METHYL)PACLITAXEL
Common Name English
7-METHYLTHIOMETHYLPACLITAXEL
WHO-DD  
Common Name English
7-((METHYLTHIO)METHYL)PACLITAXEL
Common Name English
7-methylthiomethylpaclitaxel [WHO-DD]
Common Name English
PACLITAXEL, 7-((METHYLTHIO)METHYL)-
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C67437
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
NCI_THESAURUS C1490
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
Code System Code Type Description
FDA UNII
3811W2NBZ8
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
CAS
160237-25-2
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
MESH
C426424
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
DRUG BANK
DB12633
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
EPA CompTox
DTXSID30873340
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
PUBCHEM
6918461
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
NCI_THESAURUS
C1843
Created by admin on Fri Dec 15 15:55:34 GMT 2023 , Edited by admin on Fri Dec 15 15:55:34 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY